About Insight Lifetech

We are a medtech company dedicated to developing innovative solutions with the potential to transform precision diagnosis and treatment of cardiovascular diseases.

As a leading player in the interventional cardiovascular device market, we have developed the first and only domestic fractional flow reserve (FFR) system approved by the NMPA in China.Our FFR system also obtained the CE Mark in March 2020.

Additionally, our 1st Generation Intravascular Ultrasound (IVUS) system was the first domestic IVUS system to have entered into clinical trials and completed patient enrollment in China. With our FFR and IVUS products, we are the only domestic medical device company in China with a product portfolio in both precision intravascular physiology and imaging. 

Since our inception, we have focused on developing innovative technologies to precisionize the care of cardiovascular diseases, with a vision to build a world-class medical technology company of long-lasting impact.

Led by our strong management team, and leveraging our proprietary technologies, deep industry insights, and extensive experience in research and development, we have developed a total solutions platform for the precision diagnosis and treatment of major cardiovascular diseases, including coronary artery disease, atrial fibrillation, and peripheral artery disease.

We have built a synergistic platform that seamlessly integrates our R&D, manufacturing and commercialization capabilities, thus enhancing collaboration across different functions, accelerating product development, achieving cost-efficiency and promoting innovation.

We industriously and consistently pursue our mission to transform healthcare through innovation and quality.

Our Culture
  • Our Mission
    Our Mission
    To transform healthcare through innovation and quality


    Enabling precision diagnosis and therapy to save and improve life
    Creating more intelligent solutions to improve care efficiency
    Developing trustworthy and accessible products to help more people

  • Our Vision
    Our Vision
    To build a world-class medical technology company of long-lasting impact
  • Our Values
    Our Values
    Integrity, Passion, Accountability, Craftsmanship, Inclusiveness, Growth
  • Our Talent Value Proposition
    Our Talent Value Proposition
    Mission driven; Healthy career; Innovation and creativity; Growth mindset
Our Mission
To transform healthcare through innovation and quality


Enabling precision diagnosis and therapy to save and improve life
Creating more intelligent solutions to improve care efficiency
Developing trustworthy and accessible products to help more people

Our Vision
To build a world-class medical technology company of long-lasting impact
Our Values
Integrity, Passion, Accountability, Craftsmanship, Inclusiveness, Growth
Our Talent Value Proposition
Mission driven; Healthy career; Innovation and creativity; Growth mindset
Awards & Recognition
  • 2018
    Obtained the Certificate for National High-tech Enterprises
  • 2018
    National Key R&D Scheme for Digital Medical Devices
  • 2019
    Obtained the ISO13485:2016 Certification
  • 2020
    Shenzhen Science and Technology Plan Sustainable Development Project
  • 2021
    Obtained the (ENVIRONMENTAL MANAGEMENT SYSTEM CERTIFICATION) ISO14001:2015
Development Milestone
Business Operations Product Development
  • Company established
2015
  • Built our 1st GMP facility for FFR
2016
  • Initiated the animal studies of FFR system)
  • Completed the FFR system type testing in China
2017
  • Our 1st Gen IVUS was selected as a National Key R&D Program, qualifying it for NMPA priority registration
  • Recognized as a National High-tech Enterprises
2018
  • Completed clinical trials and submitted NMPA Registration Application for our 1st Gen FFR
  • Our 1st Gen FFR was granted Special Review and Approval for Innovative Medical Devices
  • Obtained the ISO13485:2016 certificate
  • Built our 2nd GMP facility for IVUS and microcatheter sets
2019
  • CE Mark for our 1st Gen FFR
  • NMPA Registration Certificate for our 1st Gen FFR
  • CE Mark for our FFR-cRR add-on
  • Established Insight Medtech, focusing on IVL and EP solutions
2020
  • NMPA registration application for TrueCross™ single-lumen microcatheter
  • NMPA registration application for TrueReach™ dual-lumen microcatheter
  • Completed clinical trials and submitted the NMPA registration application for our 1st Gen IVUS
  • Built our 3rd GMP facility for mass production of the TruePhysioTM FFR Microcatheter
2021
Future Plans

Further develop innovative solutions with clinical value to enhance our leading market position in precision interventional diagnosis and treatment of cardiovascular diseases,

Continue to focus on precision PCI diagnosis and treatment and enrich product portfolio of precision PCI

Leverage our core technology platforms to expand horizontally and vertically into new applications and new products,

Continue our academic promotion and professional clinical support to achieve global commercialization and enhance global brand recognition,

Continue to attract international talents and identify strategic collaboration and acquisition
opportunities to expand our global footprint and maximize our product value。

Zone E, 3rd Floor, Building 3,

Tinwe Business Park, No. 6 Liufang Rd.

Baoan District, Shenzhen, P.R. China, 518101.